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AbstrACt
Objectives Given the current excellent early mortality 
rates for paediatric cardiac surgery, stakeholders 
believe that this important safety outcome should be 
supplemented by a wider range of measures. Our 
objectives were to prospectively measure the incidence 
of morbidities following paediatric cardiac surgery and to 
evaluate their clinical and health-economic impact over 
6 months.
Design The design was a prospective, multicentre, 
multidisciplinary mixed methods study.
setting The setting was 5 of the 10 paediatric cardiac 
surgery centres in the UK with 21 months recruitment.
Participants Included were 3090 paediatric cardiac 
surgeries, of which 666 patients were recruited to an 
impact substudy.
results Families and clinicians prioritised:
Acute neurological event, unplanned re-intervention, 
feeding problems, renal replacement therapy, major 
adverse events, extracorporeal life support, necrotising 
enterocolitis, postsurgical infection and prolonged pleural 
effusion or chylothorax.
Among 3090 consecutive surgeries, there were 675 
(21.8%) with at least one of these morbidities. Independent 
risk factors for morbidity included neonatal age, complex 
heart disease and prolonged cardiopulmonary bypass 
(p<0.001). Among patients with morbidity, 6-month 
survival was 88.2% (95% CI 85.4 to 90.6) compared with 
99.3% (95% CI 98.9 to 99.6) with none of the morbidities 
(p<0.001). The impact substudy in 340 children with 
morbidity and 326 control children with no morbidity 
indicated that morbidity-related impairment in quality 
of life improved between 6 weeks and 6 months. When 
compared with children with no morbidities, those with 
morbidity experienced a median of 13 (95% CI 10.2 to 
15.8, p<0.001) fewer days at home by 6 months, and an 
adjusted incremental cost of £21 292 (95% CI £17 694 to 
£32 423, p<0.001).
Conclusions Evaluation of postoperative morbidity 
is more complicated than measuring early mortality. 
However, tracking morbidity after paediatric cardiac 
surgery over 6 months offers stakeholders important data 
that are of value to parents and will be useful in driving 
future quality improvement.
bACkgrOunD
Over 5000 paediatric cardiac surgery proce-
dures are performed in the UK each year and 
early survival has improved to over 98% since 
comprehensive national audit commenced 
in 2000.1 2 Most stakeholders including 
clinicians, commissioners and users believe 
that while these early survival rates remain 
an important safety measure, it has become 
imperative to explore a broader range of 
measures for outcome in this complex field of 
practice. While there has been considerable 
research related to measuring, understanding 
and reducing perioperative mortality for 
paediatric cardiac surgery,3–5much less atten-
tion has been focused on surgical morbidities.
Morbidity is defined as a state of being 
unhealthy, or of experiencing an aspect of 
health that is ‘generally bad for you’. In this 
project, by ‘morbidity’ we mean a defined 
aspect of ill health associated with a specific 
operation. In our study, we aimed to iden-
tify which morbidities present the greatest 
burden on patients and health services 
following paediatric cardiac surgery. Views 
strengths and limitations of this study
 ► Our study is unique, given that the morbidity mea-
sures selected for study reflect the viewpoints of 
both lay people and clinicians, whereas previous 
work has tended to focus on clinical metrics only.
 ► A limitation of our study is that although we were 
able to identify broad risk factors for morbidity after 
paediatric cardiac surgery, a larger dataset will be 
needed to generate more reliable risk adjustment 
methods.
 ► A strength of our study was that it was multicentre, 
prospective and followed children up for 6 months 
after their operation, which is a longer time horizon 
than the usual 30-day period.
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may differ between professionals and non-professionals 
as to what the term morbidity exactly refers to and which 
surgical morbidities are most important.6 Therefore, we 
set out to combine patients’ and carers’ perspectives with 
those of professional groups in defining a prioritised list 
of morbidities for prospective evaluation.
Over 4 years, we:
1. Identified and defined nine morbidities following pae-
diatric heart surgery, taking into account views from 
patients, carers, psychologists, nurses and clinicians, 
which together captured important aspects of the clin-
ical and health-economic burden;
2. Measured incidence of the defined morbidities in the 
UK patient population and in subgroups defined by 
case complexity;
3. Evaluated the impact of defined morbidities on quality 
of life and estimated their clinical and health econom-
ic burden.
MethODs
Design
The design was a prospective, multicentre, multidisci-
plinary mixed methods study. Selection of morbidities 
was based on consensus methods. Morbidity incidence 
was evaluated with a prospective cross-sectional study. 
Measurement of morbidity impact entailed a prospective, 
case-matched, longitudinal study.
setting
Five UK paediatric cardiac surgery centres representing 
a range of programme sizes, which care for half of all 
patients nationally.
Participants
The participants were children aged under 17 years with 
congenital heart disease (CHD).
Consent
Parents and children participating in focus groups and 
in the prospective study of morbidity impact provided 
written informed consent.
Which morbidities?
Between January 2014 and September 2015, we reviewed 
existing literature, ran three family focus groups and 
undertook a family online discussion forum moder-
ated by the Children’s Heart Federation (a user group). 
Transcripts were thematically analysed and the resultant 
themes, together with the literature, helped to inform 
a long list of candidate surgical morbidities. A multidis-
ciplinary group, with patient and carer representation, 
then ranked and selected a list of nine key morbidities 
using the nominal group technique and secret voting.7 
This ‘selection panel’7 was informed in turn by clinical 
views on definitions and feasibility of routine monitoring 
for each candidate morbidity provided by an independent 
‘definition panel’8 as reported in previous publications.
Incidence of morbidity
Between October 2015 and June 2017, we prospectively 
measured instances of morbidity within all consecutive 
surgical admissions across the study sites. Online supple-
mentary appendix 18 provides the details of the criteria 
followed to define each individual morbidity, including 
the timeframe for diagnosis. Morbidities were attributed 
to the immediately preceding cardiac surgery and defined 
within the same hospitalisation. The only exceptions were 
unplanned re-operation, which was defined as an unan-
ticipated procedure within 30 days and mediastinitis, 
which could be identified postdischarge by the operating 
surgeon.8 Data were regularly checked for completeness, 
clinical congruence and accuracy and, a 3-month sample 
of data was independently validated against the national 
audit data.
As for the UK audit of 30-day mortality,9 all procedures 
>30 days apart on the same patient were included in the 
morbidity analysis. As a secondary outcome, we checked 
each patient’s survival status at 6 months after first appear-
ance in the dataset, based on the individual centres 
National Congenital Heart Diseases Audit (NCHDA)2 
data and local hospital records.
Impact of morbidity
Recruitment
Recruitment to the impact study ran between October 
2015 and June 2017 for all but one site, where it stopped 
after 6 months due to resource constraints. We attempted 
to recruit all patients with morbidity from the wider 
population, when at least one parent spoke reasonable 
English, and the family were resident in the UK. When 
feasible, for each morbidity case, we recruited a patient 
with no morbidity, matched on treating centre, age and 
univentricular status. The recruitment strategy led to the 
recruitment of a sample that was evenly balanced between 
patients with morbidity and those with no morbidity, 
however we were not able to find a match for every 
morbidity patient. In order to account for the widest 
possible spectrum of important outcomes, we included 
the available data on children who subsequently died.
Measures of impact
We evaluated the impact of morbidities over the 6 months 
following surgery, based on the outcomes discussed below.
Quality of life and psychological burden on children and parents
We used age-specific measures at 6 weeks and 6 months 
following surgery. These were the PedsQL subscales 
(physical and psychosocial) and total scores. These scores 
range from 0 and 100, a higher score indicating better 
quality of life. PedsQL scores in a normal healthy popula-
tion vary by age; expected scores for infants 0–12 months 
(which encompasses the median age for our cohort) are 
mean physical 84.98 (SD 9.45), mean psychosocial 80.47 
(SD 12.64) and mean total 82.47 (SD 9.95).10–12
For the parents, we used the Patient Health Ques-
tionnaire-4 (PHQ-4), which comprises four questions, 
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measuring anxiety and depression in adults. Individual 
items are scored from 0 to 3. Scores ≥3 for the first two 
questions suggest anxiety, and scores ≥3 for last two ques-
tions suggest depression.13 In the normal population, 
4.8% have scores suggestive of anxiety and 6.6% have 
PHQ-4 scores suggestive of depression.14
Days at home over 6 months as an additional measure of 
disruption to family life
Length of inpatient stay following the index procedure 
was defined as the number of days between the opera-
tion and the date of discharge from the tertiary centre. 
Hospital stays that exceeded the 6-month follow-up period 
were censored after 183 days. All subsequent hospital 
admissions were captured and the total days spent in 
hospital including tertiary and secondary care admissions 
was subtracted from 183 days to generate a value for days 
at home by 6 months. Children who died in hospital were 
assigned a value of zero for this outcome.
Costs of the index hospitalisation
We calculated the cost of the inpatient stay in the tertiary 
centre following the index surgical procedure as a key 
indicator of the economic burden to the hospital provider 
(measured in 2016/17 UK£).
Costs were calculated as the summation of days in inten-
sive care unit (ICU), days on the ward and all operating 
procedures within the defined period. For ICU stays, data 
were recorded on the level of care the patient received 
each day (enhanced care, high dependency, high depen-
dency advanced, ICU basic, ICU basic enhanced, ICU 
advanced, ICU advanced enhanced and extracorporeal 
life support (ECLS)).15 Unit costs of ICU stays were daily 
costs for each level of care (ranging from £870 to £5440) 
applied to the number of days spent receiving that level 
of care. Unit costs per day for ward stays were obtained 
from the highest recruiting centre and varied according 
to the age of the patient (<2 years, £904; ≥2 years, £680). 
Unit costs for surgical procedures were costs per minute 
supplied by study sites; these varied by site and so we used 
the value for the site that recruited the largest number of 
patients to this study (£13.39 per min), which was similar 
to the mean value across all sites.
statistical and health economic analyses
Patient sample size
We anticipated that between 3000 and 3300 surgical 
patients would be admitted across the five sites during 
the study period.2 We assumed that a clinically relevant 
difference in quality of life between matched pairs corre-
sponded to a mean difference in quality of life score of 
at least 0.5 SD.16 To detect such a difference for PedsQL 
responses at 5% significance with 80% power requires a 
minimum of 32 matched pairs. Allowing for a 10% loss to 
follow-up rate, we aimed to recruit 36 matched pairs for 
each patient with morbidity, giving 80% power to detect 
a significant effect for any morbidity with a prevalence of 
at least 1.5%.
Analysis of risk factors for morbidity
Based on the whole sample of cardiac surgeries across the 
five sites over the study period, we explored risk factors 
for occurrence of morbidity. Clinical risk factor groups 
were derived from the finer diagnostic coding, based 
on previous peer-reviewed research by our group.9 17 We 
used multilevel logistic regression analysis to explore 
the role of preoperative, patient-level case mix factors 
on the occurrence of any morbidity versus no morbidity, 
accounting for multiple procedures within patients. First, 
a univariate model to predict risk of any morbidity versus 
none was fitted for each risk factor. The estimated ORs are 
presented along with 95% CIs. Then all factors significant 
on univariate analysis (p<0.1) were considered in a multi-
variable model. We used multiple imputation by chained 
equations to account for missing data. The imputation 
model included all risk factors considered in the univar-
iate analysis, which we assumed included all predictors of 
missingness. We indicate missing data in our results. The 
multivariable models were derived by fitting a regression 
model for all significant predictors and estimates were 
combined using Rubin’s rules.18
Secondary outcome
The secondary outcome of survival at 6 months was calcu-
lated for all patients who had cardiac surgery at the sites 
within the study period. Unadjusted 6-month mortality 
rates were compared between morbidity groups using 
logistic regression.
Analysis of the impact of morbidity
In the patients recruited to the impact study, we analysed 
the ‘impact outcomes’ over 6 months postsurgery.
We used mixed effects regression models for PedsQL/
PHQ-4 results to compare the impact of morbidity (any vs 
none) on outcome. All models were adjusted for clustering 
within matched pairs and significant covariates associated 
with incidence of morbidity. We used multiple imputa-
tion, by chained equations to account for missing data for 
those patients known to be alive at 6 weeks and 6 months, 
respectively.
We used quantile regression to estimate the effects of 
individual morbidities in terms of differences in median 
days at home by 6 months, since the measure was nega-
tively skewed. All models were adjusted for clustering 
within matched pairs and significant covariates associated 
with incidence of morbidity. Given the high level of data 
completeness, imputation was not used.
The inclusion of hospital site made negligible differ-
ence to either of these analyses, and not included in the 
statistical models.
We modelled the relationship between morbidities and 
cost of index hospitalisation, adjusted for significant covari-
ates associated with hospital costs. Costs were skewed and 
to account for this we used a generalised linear model with 
gamma family and log link, which has been recommended 
for modelling positively skewed data.19 Missing outcome 
values were imputed using an iterative Markov chain Monte 
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Figure 1 Incidence of morbidities. The figure shows the distinction between occurrence as a single morbidity and occurrence 
in combination with other morbidities, with 95% CIs. Source: Reproduce from Brown et al35 2019.
Carlo procedure based on multivariate normal regres-
sion, generating 20 imputed datasets. The hospital site was 
included as a significant covariate in the health economic 
model.
All analyses were performed in Stata V.14.20
Patient and public involvement
The patient or user perspective lies at the core of the study 
methodology. Specifically, a key goal of the study was to 
consider the views of patients and parents when measures of 
morbidity are selected for future audit and benchmarking, 
in particular since emphasis may potentially differ between 
professionals and parents/patients.
Patient and family representatives from the Children’s 
Heart Federation (CHF) were involved in aspects of the 
study design including design and running of the focus 
groups and the online discussion forum.
Representatives of the CHF participated in the facilitated 
nominal group meetings to select morbidities for inclusion 
in the incidence and impact studies.
A member of the CHF and a parent representative sat 
on the project steering group.
results
Which morbidities?
Our final selected7 and defined8 list of included morbidi-
ties were: acute neurological event, unplanned re-interven-
tion, feeding problems, renal replacement therapy, major 
adverse events, ECLS, necrotising enterocolitis, postsurgical 
infection and prolonged pleural effusion or chylothorax.
We treated children with more than one of these events 
as a distinct group referred to as ‘multimorbidity’. Recog-
nising ECLS as a very severe event, which nearly always 
occurs with other morbidities, we treated ECLS as stand-
alone morbidity (and always excluded from the multiple 
morbidity group).21–25
There was some divergence between the views of clini-
cians and families about the fundamental issue of what the 
important morbidities linked to paediatric cardiac surgery 
are. Health professionals from tertiary centres tended to 
prioritise clearly clinical issues related to the heart (eg, use 
of ECLS and re-operation), whereas parents placed greater 
emphasis on holistic outcomes for their child (eg, feeding 
difficulties and child developmental problems).7
2.Incidence of morbidity
Descriptive results
We collected data on 3248 cardiac procedures and analysed 
3090, after excluding 99 cardiac re-operations (a morbidity 
outcome) and 59 procedures that did not meet inclusion 
criteria.
The incidence of individual morbidities in isolation 
and overall for each is shown in figure 1.
Significant risk factors for morbidity
As shown in table 1, the most important risk factor for 
occurrence of ‘any morbidity’ was young age, particu-
larly neonates, who were approximately five times as 
likely to experience a morbidity compared with chil-
dren aged over 1 year. Children with more complex 
heart disease or children whose operation included a 
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Table 1 Summary of risk factors by any morbidity outcome
None of the morbidities
(N=2415) Number (%) or
(IQR where stated)
Any morbidity
(N=675) Number (%) or
(IQR where stated)
Univariate OR for ‘any 
morbidity’
(95% CI), p value
Multivariable OR for ‘any 
morbidity'
(95% CI), p value
Male 1299 (53.8) 372 (55.1) 1.05 (0.89 to 1.25), 0.54 –
Median age (days) (IQR) 286 (105, 1582) 102 (10, 331)     
Child 1111 (46.0) 160 (23.7)
Infant 1023 (42.4) 268 (39.7) 1.82 (1.47 to 2.25), <0.001 1.61 (1.26 to 2.05), <0.001
Neonate 281 (11.6) 247 (36.6) 6.10 (4.81 to 7.75), <0.001 5.26 (3.90 to 7.09), <0.001
Median weight (kg) (IQR) 7.7 (4.7, 16.2) 4.6 (3.2, 8.0)     
Low weight <2 SD below mean 714 (31.5) 234 (36.8) 1.27 (1.05 to 1.52), 0.01 1.21 (0.97 to 1.51), 0.09
Cardiac diagnosis group
E—Least complex (reference) 1002 (41.5) 123 (18.2)
D 796 (33.0) 227 (33.6) 5.13 (3.79 to 6.93), <0.001 2.02 (1.58 to 2.60), <0.001
C 215 (8.9) 109 (16.2) 3.83 (2.85 to 5.13), <0.001 1.44 (1.00 to 2.07), 0.05
B 232 (9.6) 109 (16.2) 4.13 (3.07 to 5.55), <0.001 2.62 (1.85 to 3.71), <0.001
A—Most complex 170 (7.0) 107 (15.8) 2.32 (1.83 to 2.94), <0.001 2.14 (1.41 to 3.24), <0.001
Functionally univentricular heart 255 (10.6) 159 (23.6) 2.61 (2.11 to 3.23), <0.001 1.55 (1.07 to 2.24), 0.02
Acquired comorbidity 337 (14.0) 119 (17.6) 1.32 (1.05 to 1.66), 0.02 1.33 (1.03 to 1.71), 0.03
Congenital comorbidity 537 (22.2) 178 (26.4) 1.25 (1.03 to 1.52), 0.03 1.28 (1.02 to 1.59), 0.03
Severity of illness indicators 222 (9.2) 152 (22.5) 2.87 (2.30 to 3.58), <0.001 1.52 (1.16 to 2.00), <0.01
Premature <37 weeks gestation 231 (9.6) 73 (10.8) 1.15 (0.87 to 1.51), 0.33 –
Down syndrome 214 (8.9) 63 (9.3) 1.06 (0.79 to 1.43), 0.71 –
Additional cardiac risk 165 (6.8) 65 (9.6) 1.45 (1.09 to 1.94), 0.01 1.39 (0.99 to 1.94), 0.05
Surgical procedure type
Reparative/corrective (reference) 1391 (57.6) 332 (49.2)
Palliative/staged 331 (13.7) 179 (26.5) 2.27 (1.82, to 2.82), <0.001 1.65 (1.14 to 2.38), <0.01
Ungrouped 693 (28.7) 164 (24.3) 0.99 (0.81 to 1.22), 0.94 1.04 (0.82 to 1.31), 0.75
Median bypass time (min) (IQR) 72 (42, 110) 110 (62, 156)     
No bypass (reference) 390 (16.2) 103 (15.3)
Up to 90 min 1148 (47.5) 150 (22.2) 0.48 (0.35 to 0.65), <0.001 0.78 (0.57 to 1.09), 0.14
>90 min 877 (36.3) 422 (62.5) 1.76 (1.32 to 2.34), <0.001 2.28 (1.67 to 3.12), <0.001
The weight was missing in 87 (2.8%) procedures and weight for age was set to missing for an additional 99 (3.2%) patients in whom the value was 
>5 SD from the normative mean. Other data were complete. Values include imputed data.
Cardiac diagnosis group (A) hypoplastic left heart syndrome, truncus arteriosus, pulmonary atresia intact septum, (B) functionally univentricular heart, 
pulmonary atresia ventricular septal defect, (C) transposition of the great arteries all types, interrupted aortic arch, totally anomalous pulmonary 
venous connection, (D) patent ductus arteriosus, tricuspid valve anomalies, acquired heart disease, complete atrioventricular septal defect, (E) 
tetralogy of Fallot, mitral valve anomalies, isolated aortic stenosis, aortic regurgitation, aortic arch obstruction, subaortic obstruction, ventricular 
septal defect, atrial septal defect.
The results of the multiple logistic regression model for occurrence of ‘any morbidity’ are expressed as OR for ‘any morbidity’ by the stated factor, 
adjusted for age band, low weight, cardiac diagnostic category, functionally univentricular heart, acquired comorbidity, congenital comorbidity, 
severity of illness indicators, additional cardiac risk factors, specific procedure group, bypass time category.
Source: Reproduce from Brown et al35 2019
bypass time longer than 90 min were almost twice as 
likely to experience morbidity. Other important inde-
pendent risk factors were: palliative or staged proce-
dures, the presence of functionally univentricular heart 
and preprocedure severity of illness factors (eg, prepro-
cedure mechanical ventilation or shock).
Secondary outcomes
Patient survival was highest and patient hospital stay 
was shortest for patients with none of the morbidities 
(table 2). The 6-month survival was significantly lower 
for patients with a single morbidity, for those with ECLS 
and multiple morbidities, compared with patients with 
none of the morbidities (p<0.001 for all).
Impact of morbidity
Patient sample
We recruited 60% of eligible families, amounting 
to 666 children of whom 340 (51%) had at least one 
morbidity. Of these, 19 died within 30 days and 39 died 
within 6 months. We pair matched 558 patients and 108 
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Table 2 Secondary outcomes of hospital stay and survival at 6 months by morbidity
Morbidity type
Number (%) with 
morbidity
Median length of postoperative 
hospital stay in days (IQR)
6-month survival
Number, % (95% CI)
No morbidity 2415 (78.2%) 8 days
(5, 13)
2202/2217
99.3% (98.9 to 99.6)
Any morbidity 675 (21.8%) 24 days 675 (21.8%)
Acute neurological event 14 (0.5) 19 days
(12, 39)
12/13
92.3% (64.0 to 99.8)
Unplanned re-intervention 59 (1.9%) 22 days
(14, 33)
50/54
92.6% (82.1 to 97.9)
Feeding problems 99 (3.2%) 20.5 days
(12, 36)
90/91
98.9% (94 to 100)
Renal support 40 (1.3%) 17 days
(14, 26)
37/39
94.9% (82.7 to 99.4)
Major adverse event 34 (1.1) 16.5 days
(8, 25)
28/33
84.9% (68.1 to 94.9)
Necrotising enterocolitis 32 (1.0%) 24.5 days
(18.5, 49.5)
28/30
93.3% (77.9 to 99.2)
Postsurgical infection 27 (0.9%) 20.5 days
(11, 28)
25/25
100% (86.3 to 100)
Prolonged pleural effusion 111 (3.6%) 20 days
(14, 28)
95/96
99.0% (94.3 to 100)
Multimorbidity 197 (6.4) 35 days
(22, 56)
158/190
83.2% (77.1 to 88.2)
Extracorporeal life support 62 (2.0%) 43 days
(20, 84)
31/57
54.4% (40.7 to 67.6)
The number (%) of morbidities was based on individual surgical episode, as was the length of stay, whereas survival was calculated per 
patient. Data are presented based on morbidity in isolation, multimorbidity and extracorporeal life support. Length of stay data were missing 
for 9 patients and life status was missing in 16 patients who were not included.
patients unmatched of whom 61 had morbidity; all of 
the patients were included in the statistical analysis.
Quality of life and anxiety—depression outcomes
For the 6 weeks data, a comparison between patients 
with missing versus non-missing data indicated the only 
difference was in the proportions with severity of illness 
factors and additional cardiac risk factors. Importantly, 
there was no difference in the proportion of patients 
with or without morbidity. At the 6 months mark, there 
was no difference in any baseline factor or morbidity 
occurrence.
All PedsQL scores were lower than in a healthy popu-
lation (see ‘Methods’ section10–12 and table 3). In terms 
of our study objective to assess the impact of morbidity, 
the total PedsQL scores were significantly reduced for 
children with any morbidity at 6 weeks in comparison to 
children with none of the morbidities (case mix adjusted 
score reduction of −5.2 (95% CI −8.3 to –2.2, p<0.01). 
On a positive note, this difference narrowed to small 
non-significant reduction in total score by 6 months. 
Physical scores were affected more than psychosocial 
scores, and were still significantly impaired at 6 months.
All parents experienced higher rates of both anxiety 
and depression than a healthy population (see 
‘Methods’ section and table 3). The parents of chil-
dren with morbidity were around 57% more likely 
to experience anxiety; and around 77% more likely 
to experience depression, at 6 weeks postoperation 
than parents of children without a morbidity. PHQ-4 
scores had improved by 6 months, and although there 
remained a higher chance of both anxiety and depres-
sion with morbidity, the difference narrowed and was 
not significant.
Days at home by 6 months outcome
Children with none of the morbidities had a median 
of 174 days at home (IQR 169, 176) out of a possible 
183 days in 6 months. The presence of any morbidity 
reduced the median days at home by 13 days over 
6 months (95% CI 10.2 to 15.8, p<0.001). When indi-
vidual morbidities were each considered in turn, the 
difference in the case mix adjusted median days at 
home was significantly lower at 6 months for all of them 
apart from ‘renal support’ (p<0.05).
Health economic outcome
The costs of the index hospitalisation were available 
for 613 patients (8% missing). The mean additional 
cost linked to having any of the selected morbidities 
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Table 3 Quality of life and parental anxiety/depression based on whether or not a morbidity was present
The impact outcome type and 
time point of measurement
Patients with none of 
the morbidities
Patients with any 
morbidity
Differences in outcome based on presence of 
any morbidity
Score mean (SD) Score mean (SD) Adjusted difference in mean score with 
morbidity (95% CI), p value
Physical QOL score at 6 weeks 79.0 (16.2) 69.1 (21.8) −8.3 (−11.8 to –4.9), <0.001
Psychosocial QOL score at 
6 weeks
79.4 (14.7) 75.2 (19.0) −2.7 (−5.9 to 0.5), 0.08
Total QOL score at 6 weeks 79.3 (13.8) 72.1 (19.1) −5.2 (−8.3 to –2.2), <0.01
Physical QOL score at 6 months 82.3 (16.6) 76.6 (18.6) −4.2 (-7.6 to –0.8), 0.02
Psychosocial QOL score at 
6 months
78.0 (14.7) 76.4 (15.4) −0.9 (-3.5 to 1.8), 0.5
Total QOL score at 6 months 79.8 (13.9) 76.6 (15.0) −2.3 (-4.9 to 0.3), 0.08
Number (%) with 
attribute
Number (%) with 
attribute
Adjusted OR for outcome by morbidity 
(95% CI), p value
Parental anxiety at 6 weeks 55 (23.7) 92 (36.8) 1.57 (1.04 to 2.35), 0.03
Parental depression at 6 weeks 26 (11.2) 55 (22.1) 1.77 (1.10 to 2.86), 0.02
Parental anxiety at 6 months 23 (11.5) 34 (17.4) 1.37 (0.77 to 2.43), 0.28
Parental depression at 6 months 15 (7.5) 23 (11.9) 1.45 (0.79 to 2.68), 0.23
The differences in each outcome are adjusted for age band, low weight, cardiac diagnostic category, functionally univentricular heart, 
acquired comorbidity, congenital comorbidity, severity of illness indicators, additional cardiac risk factors, specific procedure group, 
bypass time category.
Values include imputed data.
Quality of life was derived from PedsQL scores for 478 children at 6 weeks (26% missing) and 403 children at 6 months (36% missing).
Parental anxiety and depression was derived from PHQ-4 responses of 481 parents at 6 weeks (26% missing) and 394 parents at 
6 months (37% missing).
PHQ-4, Patient Health Questionnaire-4; QOL, quality of life.
Table 4 Cost of hospital stay following index surgical procedure by morbidity
Morbidity Coefficient Marginal effect (£) (95% CI), p value
Any morbidity (n=340) 0.71 21 292 (17 694 to 32 423), <0.001
Acute neurological event (n=6) 0.50 13 911 (−3923 to 50 059), 0.16
Unplanned re-intervention (n=26) 0.62 18 330 (7475 to 33 282), <0.01
Feeding morbidity (n=45) 0.55 15 541 (7200 to 26 326), <0.01
Renal support (n=24) 0.41 10 798 (1846 to 23 215), 0.01
Major adverse event (n=22) 0.30 7555 (−1131 to 19 984), 0.10
Necrotising enterocolitis (n=11) 0.37 9547 (−2173 to 28 454), 0.13
Postsurgical infection (n=11) 0.27 6466 (−3947 to 23 130), 0.17
Prolonged pleural effusion (n=50) 0.33 8177 (1444 to 16 904), 0.01
Extracorporeal life support (n=27) 1.37 62 452 (39 546 to 93 983), <0.01
Multimorbidity (n=118) 0.94 33 147 (23 669 to 44 624), <0.01
The marginal effects are adjusted for age band; weight-by-age z-score; congenital morbidity, severity of illness indicator, Down 
syndrome; cardiac diagnosis category; cardiac procedure category; whether or not the patient died within 6 months and study site.
Figures in the ‘Marginal effect’ column are the mean difference in costs between each morbidity category and the category of no 
selected morbidities present, conditional on the covariates. Costs are in 2016/17 UK£. Values include imputed data.
was £21 292 (95% CI £17 694 to £32 423, p<0.001). In 
table 4, we present the adjusted marginal effects, which 
are the adjusted incremental costs linked to the stated 
morbidity, in comparison to the adjusted cost linked 
to patients with none of the selected morbidities. The 
greatest adjusted cost difference was for ECLS, where 
the adjusted mean difference in costs was £62 452 
followed by multimorbidity, where the adjusted mean 
difference was £33 147 (p<0.01 for both). Significantly 
increased (p<0.05) costs were also found for unplanned 
re-intervention, feeding problems, renal support and 
prolonged pleural effusion. The remaining morbid-
ities, representing the lowest number of patients per 
category, showed non-significant differences.
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DIsCussIOn
Overview of findings
This paper presents the results of the first prospective 
multicentre study of morbidity after paediatric cardiac 
surgery morbidity that measured outcome 6 months after 
operation. The results are novel and indicate that evalu-
ation of morbidity adds considerably to the current main 
metric of 30-day or in-hospital survival.
We note the excellent outcomes in children who had 
none of the morbidities: their survival at 6 months post-
operation was 99.3% and their median length of stay 
was 8 days, suggesting that the morbidities we selected 
do capture most of the complication-related adverse 
outcomes for this context.
Based on our impact substudy, occurrence of ECLS and 
multiple morbidities are particularly important adverse 
outcomes—they are associated with high mortality, high 
resource use and lower quality of life for surviving patients 
over 6 months after surgery. Future routine monitoring 
and public reporting for these should be considered by 
centres and the national audit.
In our engagement work, patients’ families consistently 
told us that outcomes affecting the child as a whole over 
the medium or long term are very important to them. 
We thus included morbidities such as feeding problems 
and acute neurological events but note that those types 
of outcome were the most complicated to capture, and 
we intend to publish additional material on these topics.
limitations
We acknowledge that the definition, measurement, 
reporting and interpretation of morbidity are much more 
complex than for mortality. This activity requires signif-
icant staff resources and clinician buy in, in particular 
because some morbidities are challenging to measure 
and to interpret. The number of individual morbidities 
was low in some of our analyses, limiting interpretation. 
We have not captured every single morbidity that exists 
after children’s heart surgery.
Context
There have been previous attempts at reporting 
morbidity after paediatric cardiac surgery, however these 
have in general captured events within a hospital setting, 
whereas our study captures outcomes out to 6 months 
postsurgery.A single centre study generated an aggre-
gate 'Morbidity Index' by assigning subjective weights to 
postoperative complications.26The Society of Thoracic 
Surgery in the USA, developed a ‘Morbidity Score’, based 
on data from their multicentre registry.27 We note that 
condensing diverse morbidities into a single score may 
lead to loss of information. Moreover, recent work on 
using graphical methods to routinely monitor a range 
of morbidities highlighted the complexity of graphi-
cally summarising multiple morbidities.28 The Pediatric 
Cardiac Critical Care Consortium (PC⁴) was set up in 
2009, and provides partner sites with access to real-time, 
reliable and actionable data to be used for local quality 
improvements.29–32 However, membership of PC4 is volun-
tary for institutions on a subscription basis, the reported 
measures been selected by clinicians, the reporting of 
outcomes is accessible only to subscribing member insti-
tutions and these are limited to in-hospital measures.
Future PrACtICe AnD reseArCh
Neurodevelopmental problems are common in children 
with CHD undergoing surgery33; however, we detected 
acute neurological events (ANE) following only 2.1% 
of procedures. Therefore, it appears that perioperative 
‘ANE’ represents the tip of the iceberg, and hence the 
scope of surveillance for child neurodevelopment in CHD 
needs to extend well beyond the perioperative period.
Despite their great importance to families, we note 
that participants reported subjectivity in the collection of 
data on ‘feeding problems’; hence, these were difficult to 
capture consistently. Additional research may help deter-
mine the best way to measure this important morbidity 
and to elucidate approaches to alleviate the impact of 
feeding problems in CHD.
Our measure of renal failure was the need for renal 
support, and although relatively easy data to collect this 
may not be the optimal method to capture this morbidity, 
given that there are differences in practice between clini-
cians.34 Further research may help us to understand the 
best approach to manage postoperative renal injury in 
CHD.
Our results perhaps unsurprisingly indicate that 
parents of children who suffer morbidities experience 
higher rates of anxiety and depression postoperatively. 
This emphasises the importance of supporting parents 
during this phase.
We used study data to co-develop parent and carer infor-
mation resources, showing what the morbidities are and 
how their incidence and the length of stay may vary based 
on the complexity of the child’s condition. Parents told us 
that it helps to know that first, they are not alone in facing 
a morbidity second, clinical teams have seen morbidities 
before and know how to deal with them, and third, it is 
better as a parent to ‘be prepared’. Furthermore, parents 
indicated that information about impact such as nearly 
all children who experience a morbidity and recover will 
have a similar quality of life to children who did not expe-
rience a morbidity by the 6-month mark, was very helpful 
to know.
Within the scope of this project, a new Excel tool has 
been developed and piloted, which enables clinical teams 
to benchmark and report the local rates of morbidities 
with a quality assurance goal, such as in a mortality and 
morbidity conference. Furthermore, we have kept in 
close contact with the NCHDA and the Clinical Refer-
ence Group for CHD services. The NCHDA has already 
started to collect five of the nine morbidities within the 
nationally mandated dataset, using the definitions that we 
developed.
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